Skip to product information
1 of 1

CXCL13 Recombinant Rabbit mAb (SDT-2703-132)

CXCL13 Recombinant Rabbit mAb (SDT-2703-132)

Catalog Number: S0B2454 Application: IHC-P, IF Reactivity: Human Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen CXCL13
Synonyms C-X-C motif chemokine 13; Angie; B cell-attracting chemokine 1 (BCA-1); B lymphocyte chemoattractant; CXC chemokine BLC; Small-inducible cytokine B13; BCA1; BLC; SCYB13
Immunogen Recombinant Protein
Location Secreted
Accession O43927
Clone Number SDT-2703-132
Antibody Type Recombinant mAb
Isotype IgG
Application IHC-P, IF
Reactivity Hu
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
IHC-P 1:500 Hu
IF 1:100 Hu

Background

CXCL13, also called BCA-1 or BLC, is a homeostatic CXC chemokine that acts as the main chemoattractant for B lymphocytes and follicular helper T cells through exclusive binding to the G-protein-coupled receptor CXCR5, thereby guiding their migration into lymphoid follicles and organizing the microarchitecture of secondary lymphoid organs such as lymph nodes and spleen; secreted chiefly by follicular dendritic cells, stromal cells, and macrophages, it triggers downstream signaling cascades including PLC-β/PKCα, MAPK, PI3K-Akt, and NF-κB that promote chemotaxis, adhesion, and survival of B cells, and its dysregulation—manifested by elevated serum or tissue levels—has been mechanistically linked to autoimmune diseases (e.g., rheumatoid arthritis, Sjögren’s syndrome, systemic lupus erythematosus), chronic inflammatory disorders, B-cell malignancies, and neuroinflammatory conditions like multiple sclerosis, making it both a pathogenic driver and a clinically useful biomarker for disease activity and prognosis.

Picture

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human tonsil. Anti-CXCL13 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human spleen. Anti-CXCL13 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded human kidney. Anti-CXCL13 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human gastric cancer. Anti-CXCL13 antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Immunofluorescence

IF shows positive staining in paraffin-embedded human tonsil. Anti-CXCL13 antibody was used at 1/100 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. Counterstained with DAPI (Blue). Heat mediated antigen retrieval with EDTA buffer pH9.0 was performed before commencing with IF staining protocol.